Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Starts SolarEdge Technologies (SEDG) at Buy
-
Orsu Metals Corporation: Expiry of Options
-
Minera IRL Announces Passing of Founding Director Courtney Chamberlain
-
Aldeyra Therapeutics (ALDX) to Offer 3M Common Shares
-
Aduro Biotech Announces Close of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Concurrent Private Placement
-
Canaccord Genuity Expands Western Canadian Investment Banking Capability With Senior Hire
-
Buy Heartware (HTWR) on Weakness, Canaccord Genuity Says; PT to $106
-
SCYNEXIS Announces Launch of Public Offering of Common Stock
-
CMP 2015 Resource Limited Partnership Raises $14.8 Million on First Closing
-
Canadian Banc Corp. Completes Overnight Offering of $30,690,000
-
KemPharm (KMPH) IPO Opens Up 7%
-
Canaccord Genuity Starts CEVA Inc. (CEVA) at Buy
-
KemPharm Announces Pricing of Initial Public Offering
-
Notable Analyst Rating Changes 4/15: (GPRO) (DFS) (EVEP) Upgraded; (BLDR) (MPEL) (FMSA) Downgraded
-
Aduro Biotech (ADRO) IPO Opens Up 88%
-
Stratasys (SSYS) Price Target, Estimates Cut at Canaccord Genuity; 'Buy' Maintained
-
Canaccord Genuity Downgrades NuVasive (NUVA) to Hold
-
Canaccord Genuity Downgrades Gran Tierra Energy (GTE) to Hold
-
Aduro Biotech Announces Pricing of Its Initial Public Offering
-
Shopify (SHOP) Files $100 Million IPO
-
Shopify Files For Proposed Initial Public Offering
-
Aqua-Pure Ventures Inc. Engages Canaccord Genuity Corp. to Evaluate Strategic Alternatives
-
The Inter-American Development Bank (IDB) and Next Billion: Women & the Economy of the Future Conference to Shine Light on Role of Women in Business
-
Quest Diagnostics (DGX) PT Raised to $85 at Canaccord Genuity
-
Aduro Biotech (ADRO) Sees IPO Price of $17/Share
-
Netflix (NFLX) PT Raised to $530 at Canaccord Genuity Ahead of Q1 Print
-
theScore Reports Record Quarterly Revenue
-
GrubHub (GRUB) Q1 Estimates 'Seem Reasonable', Canaccord Genuity Says
-
Loyalist Appoints Shant Poladian as Division President to Lead Student Housing Initiative
-
Dalradian Announces Change to Board of Directors
-
Notable Analyst Rating Changes 4/10: (NFLX) (M) (KNX) Upgraded; (CAB) (HBHC) (AAPL) Downgraded
-
UPDATE: Canaccord Genuity Starts Vertex (VRTX) at Buy
-
Canaccord Genuity are Buyers of AngioDynamics (ANGO) on Weakness
-
UPDATE: Canaccord Genuity Downgrades Whiting Petroleum (WLL) to Hold
-
Cerulean Closes Public Offering of Common Stock
-
Qorvo (QRVO) PT Raised to $85 at Canaccord Genuity
-
Apple (AAPL) PT Raised to $150 at Canaccord Genuity
-
Notable Analyst Rating Changes 4/9: (IHG) (AUQ) (PTEN) Upgraded; (CTXS) (PHM) (CLF) Downgraded
-
Canaccord Genuity Upgrades AuRico Gold (AUQ) to Buy
-
Rubicon Minerals Announces Closing of C$30.2 Million Flow-Through Financing
-
Cantor Fitzgerald Expands Consumer Equity Research Group
-
Kornit Announces Closing of Initial Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Medivation (MDVN) PT Lifted to 'Street High' $180 at Canaccord Genuity
-
UPDATE: Cantor Fitzgerald Starts BioDelivery Sciences International (BDSI) at Buy
-
EMED Mining Public Limited ("EMED" or the "Company"): Further US$6 million From Unsecured Bridging Finance Facility
-
Astronics (ATRO) PT Raised to $80 at Canaccord Genuity
-
Cerulean Pharma (CERU) Prices 5.84M Common Offering at $6/Share
-
Cerulean Announces Pricing of Public Offering of Common Stock
-
The Next Billion: Women & The Economy of the Future Conference Announces Roster of Notable Speakers for May 7 Event
-
Orsu Metals Corporation: New Exclusivity Agreement for Potential Sale of Akdjol-Tokhtazan Project

